TALS - Talaris shareholders approve merger 1-for-10 reverse stock split
2023-10-17 18:51:58 ET
More on Talaris Therapeutics
- Talaris sells kidney transplant asset FCR001 to ImmunoFree
- Seeking Alpha’s Quant Rating on Talaris Therapeutics
- Historical earnings data for Talaris Therapeutics
- Financial information for Talaris Therapeutics
For further details see:
Talaris shareholders approve merger, 1-for-10 reverse stock split